The role of MIP-1 alpha in inflammation and hematopoiesis

D N Cook1

  • 1Department of Pathology, University of North Carolina, Chapel Hill 27599-7525, USA.

Insights

Macrophage inflammatory protein 1 alpha (MIP-1 alpha) is not essential for normal hematopoiesis but plays a key role in inflammatory responses to viruses. Inhibiting MIP-1 alpha may help control inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Hematology

Background:

  • Macrophage inflammatory protein 1 alpha (MIP-1 alpha) is a C-C chemokine with known proinflammatory activities.
  • MIP-1 alpha also exhibits inhibitory effects on hematopoietic stem cell proliferation.
  • Its precise role in vivo, particularly in inflammatory responses, requires further elucidation.

Purpose of the Study:

  • To review the biological properties of MIP-1 alpha.
  • To analyze the consequences of MIP-1 alpha gene disruption in mice.
  • To assess the necessity of MIP-1 alpha for normal hematopoiesis and inflammatory responses.

Main Methods:

  • Review of existing literature on MIP-1 alpha.
  • Analysis of data from mice homozygous for a disrupted MIP-1 alpha gene (MIP-1 alpha null mice).
  • Assessment of peripheral blood and bone marrow cell populations in null mice.
  • Evaluation of inflammatory responses to influenza virus and coxsackievirus-induced myocarditis in null mice.

Main Results:

  • MIP-1 alpha null mice exhibit normal peripheral blood and bone marrow cell counts, indicating no essential role in hematopoiesis.
  • MIP-1 alpha null mice show a reduced inflammatory response to influenza virus.
  • MIP-1 alpha null mice are resistant to coxsackievirus-induced myocarditis.
  • These findings highlight MIP-1 alpha's requirement for normal inflammatory responses to specific viral infections.

Conclusions:

  • MIP-1 alpha is not indispensable for maintaining normal hematopoiesis.
  • MIP-1 alpha is crucial for mounting effective inflammatory responses against certain viral pathogens.
  • Targeting MIP-1 alpha activity presents a potential therapeutic strategy for managing inflammation in viral infections.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...